What is Protagonist Therapeutics's common stock?

Protagonist Therapeutics (PTGX) reported common stock of $1K in Q1 2026.

How has Protagonist Therapeutics's common stock changed year-over-year?

Protagonist Therapeutics's common stock decreased by 0.0% year-over-year, from $1K to $1K.

What is the long-term trend for Protagonist Therapeutics's common stock?

Over 2 years (2023 to 2025), Protagonist Therapeutics's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $1K to $1K.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Protagonist Therapeutics PTGX Common Stock

Common Stock at other companies

Bristol-Myers SquibbBMY

$292M0.0%

Eli LillyLLY

$590M-0.4%

AmgenAMGN

2.8B0.0%

IncyteINCY

400M0.0%

AbbVieABBV

$18M0.0%

Apogee Therapeutics, Inc.APGE

——

Other financials

Income statement

See full

Revenue$56.4M+99.0%

Operating income-$3.6M+81.1%

Net income$3.8M+132%

EPS (diluted)$0.05+126%

Balance sheet

See full

Cash & equivalents$193.7M+38.7%

Total debt$9.8M-13.9%

Total equity$655.5M-4.9%

Total assets$697.5M-6.0%

Cash flow

See full

Operating cash flow-$48.9M-139%

CapEx$215.0K-60.6%

Free cash flow-$49.2M-139%

Valuation

See full

Market cap$7.26B+127%

Enterprise value$7.07B+130%

P/S98×+82.6×

Profitability

See full

Operating margin-192.4%-205pp

Net margin-154.9%-182pp

FCF margin-12,264.3%-12,527pp

Returns & leverage

See full

Return on equity-17.1%-26.1pp

Debt / equity0×0.0×

Current ratio17.8×+0.5×

Where this comes from

Reported directly by Protagonist Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CommonStockValue.

The official record: Protagonist Therapeutics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Protagonist Therapeutics's common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Protagonist Therapeutics's common stock?: Protagonist Therapeutics (PTGX) reported common stock of $1K in Q1 2026.
How has Protagonist Therapeutics's common stock changed year-over-year?: Protagonist Therapeutics's common stock decreased by 0.0% year-over-year, from $1K to $1K.
What is the long-term trend for Protagonist Therapeutics's common stock?: Over 2 years (2023 to 2025), Protagonist Therapeutics's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $1K to $1K.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).